Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants.
- DOI
- 10.1128/aac.01770-25
- Published
- 2026 May 6
- Container
- Antimicrobial agents and chemotherapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/aac.01770-25,
title = {Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants.},
author = {Morita J and Hida N and Yonemura T and Yamazaki T and Sato H and Sumiya M and Takaya R and Kumagai Y and Uchida N},
year = {2026},
journal = {Antimicrobial agents and chemotherapy},
doi = {10.1128/aac.01770-25},
url = {https://doi.org/10.1128/aac.01770-25}
}RIS
TY - JOUR TI - Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants. AU - Morita J AU - Hida N AU - Yonemura T AU - Yamazaki T AU - Sato H AU - Sumiya M AU - Takaya R AU - Kumagai Y AU - Uchida N PY - 2026 JO - Antimicrobial agents and chemotherapy DO - 10.1128/aac.01770-25 UR - https://doi.org/10.1128/aac.01770-25 ER -
APA
J, M., N, H., T, Y., T, Y., H, S., M, S., R, T., Y, K., & N, U. (2026). Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.01770-25
Source records
- pubmed · retrieved 2026-09-27T07:26:25.440Z